Shinva Medical Instrument Co., Ltd.

Shanghai Stock Exchange 600587.SS

Shinva Medical Instrument Co., Ltd. Price to Sales Ratio (P/S) on January 27, 2025: 0.95

Shinva Medical Instrument Co., Ltd. Price to Sales Ratio (P/S) is 0.95 on January 27, 2025, a -6.11% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Shinva Medical Instrument Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 1.12 on November 12, 2024, which is 17.55% above the current Price to Sales Ratio (P/S).
Shinva Medical Instrument Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 0.70 on June 20, 2024, which is -26.77% below the current Price to Sales Ratio (P/S).
Shinva Medical Instrument Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.93.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 600587.SS

Shinva Medical Instrument Co., Ltd.

CEO	Mr. Baoxian Gong
IPO Date	Sept. 27, 2002
Location	China
Headquarters	No. 7 Taimei Road
Employees	8,209
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Shinva Medical Instrument Co., Ltd. provides medical instruments and equipment in the People's Republic of China. It offers CSSD integrated solutions, pharmaceutical equipment integrated solutions, radiotherapy integrated solutions, digital operating room integrated solutions, dental integrated solutions, medical environmental protection integrated solutions, experiment animal safeguard integrated solutions, in vitro diagnostic reagents and instruments, and biomedical materials and supplies. The company also provides pharmaceutical machinery and air purifiers. Shinva Medical Instrument Co., Ltd. was founded in 1943 and is headquartered in Zibo, the People's Republic of China.

Key trends

Past 5 years